296 related articles for article (PubMed ID: 17531623)
1. New frameless and framed intrauterine devices and systems - an overview.
Wildemeersch D
Contraception; 2007 Jun; 75(6 Suppl):S82-92. PubMed ID: 17531623
[TBL] [Abstract][Full Text] [Related]
2. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
3. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
Wildemeersch D; Janssens D; Vrijens M; Weyers S
Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
[TBL] [Abstract][Full Text] [Related]
4. Intrauterine devices. The optimal long-term contraceptive method?
Fortney JA; Feldblum PJ; Raymond EG
J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
[TBL] [Abstract][Full Text] [Related]
5. Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine system.
Andrade AT; Souza JP; Andrade GN; Rowe PJ; Wildemeersch D
Contraception; 2004 Aug; 70(2):173-7. PubMed ID: 15288225
[TBL] [Abstract][Full Text] [Related]
6. Use of frameless intrauterine devices and systems in young nulliparous and adolescent women: results of a multicenter study.
Wildemeersch D; Jandi S; Pett A; Nolte K; Hasskamp T; Vrijens M
Int J Womens Health; 2014; 6():727-34. PubMed ID: 25125987
[TBL] [Abstract][Full Text] [Related]
7. Selection and performance of the levonorgestrel-releasing intrauterine system.
Lähteenmäki P; Bardin CW; Elomaa K; Haukkamaa M; Kivijärvi A; Kuukankorpi A; Venhola M; Tuominen J
Acta Obstet Gynecol Scand Suppl; 1997; 164():69-74. PubMed ID: 9225643
[TBL] [Abstract][Full Text] [Related]
8. Intrauterine devices and intrauterine systems.
ESHRE Capri Workshop Group
Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
[TBL] [Abstract][Full Text] [Related]
9. Treatment of primary and secondary dysmenorrhea with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E; Wildemeersch P
Eur J Contracept Reprod Health Care; 2001 Dec; 6(4):192-8. PubMed ID: 11848648
[TBL] [Abstract][Full Text] [Related]
10. The levonorgestrel intrauterine system in nulliparous women.
Prager S; Darney PD
Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
[TBL] [Abstract][Full Text] [Related]
11. Three-year efficacy and acceptability of the GyneFix 200 intrauterine system.
Cao X; Zhang W; Zhao X; Lin N; Wang L; Li C; Song L; Zhang W; Zhang Z; Wildemeersch D
Contraception; 2004 Mar; 69(3):207-11. PubMed ID: 14969668
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development.
Shaamash AH; Sayed GH; Hussien MM; Shaaban MM
Contraception; 2005 Nov; 72(5):346-51. PubMed ID: 16246660
[TBL] [Abstract][Full Text] [Related]
13. Intrauterine contraception--what now and what next?
Guillebaud J
Eur J Contracept Reprod Health Care; 2001 Jan; 6 Suppl 1():11-4. PubMed ID: 11336428
[TBL] [Abstract][Full Text] [Related]
14. Menstrual blood loss in women using the frameless FibroPlant LNG-IUS.
Andrade A; Wildemeersch D
Contraception; 2009 Feb; 79(2):134-8. PubMed ID: 19135571
[TBL] [Abstract][Full Text] [Related]
15. Intrauterine levonorgestrel delivery with frameless fibrous delivery system: review of clinical experience.
Wildemeersch D; Andrade A; Goldstuck ND; Hasskamp T; Jackers G
Int J Womens Health; 2017; 9():49-58. PubMed ID: 28176932
[TBL] [Abstract][Full Text] [Related]
16. [Intrauterine copper contraceptive implants].
Van Kets H; Thiery M; Wildemeersch D; Delbarge W; Vrijens M; Van der Pas H; Depypere H; Parewijck W; Temmerman M; Van Trappen Y; Van den Ostende G
Contracept Fertil Sex; 1996 Dec; 24(12):908-11. PubMed ID: 9026279
[TBL] [Abstract][Full Text] [Related]
17. GyneFIX. The frameless intrauterine contraceptive implant--an update for interval, emergency and postabortal contraception.
Wildemeersch D; Batár I; Webb A; Gbolade BA; Delbarge W; Temmerman M; Dhont M; Guillebaud J
Br J Fam Plann; 1999 Jan; 24(4):149-59. PubMed ID: 10023101
[TBL] [Abstract][Full Text] [Related]
18. Intrauterine devices and adolescents.
Gold MA; Johnson LM
Curr Opin Obstet Gynecol; 2008 Oct; 20(5):464-9. PubMed ID: 18797269
[TBL] [Abstract][Full Text] [Related]
19. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial.
Sääv I; Aronsson A; Marions L; Stephansson O; Gemzell-Danielsson K
Hum Reprod; 2007 Oct; 22(10):2647-52. PubMed ID: 17652452
[TBL] [Abstract][Full Text] [Related]
20. The force required to remove the frameless 0-suture IUD anchoring system: comparison between pre- and postmenopausal women.
Wildemeersch D
Contraception; 2004 Jun; 69(6):513-5. PubMed ID: 15157799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]